Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Financing Activities (2021 - 2025)

Biote (BTMD) has 5 years of Cash from Financing Activities data on record, last reported at -$4.9 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 179.13% year-over-year to -$4.9 million; the TTM value through Sep 2025 reached -$44.4 million, up 35.41%, while the annual FY2024 figure was -$76.1 million, 429.09% down from the prior year.
  • Cash from Financing Activities reached -$4.9 million in Q3 2025 per BTMD's latest filing, up from -$27.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $319.0 million in Q1 2021 and bottomed at -$329.5 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is -$4.3 million, with a median of -$4.9 million recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 125.57% in 2022, then crashed 1065.92% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$5.2 million in 2021, then grew by 23.39% to -$4.0 million in 2022, then skyrocketed by 36.49% to -$2.5 million in 2023, then crashed by 293.43% to -$9.9 million in 2024, then surged by 50.32% to -$4.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$4.9 million in Q3 2025, -$27.2 million in Q2 2025, and -$2.3 million in Q1 2025.